OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Adam Boxer

2 Projects | 1 Researchers | $175,000 Invested

2011

The Regents of the University of California, San Francisco

Adam Boxer, MD, PhD

Biomarker Optimization for Progranulin Trials

  • Funding Amount: $75,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: Other
  • Status: Closed

2008

The Regents of the University of California, San Francisco

Adam Boxer, MD, PhD

A Pilot Clinical Trial of NAP (AL-108) for Corticobasal Degeneration and Frontotemporal Lobar Degeneration with Predicted Corticobasal Degeneration Pathology

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Status: Closed